1,135
Views
61
CrossRef citations to date
0
Altmetric
Original Articles

DEATH ANXIETY IN CLINICAL AND NON-CLINICAL GROUPS

Pages 251-259 | Received 01 Jun 2004, Accepted 26 Oct 2004, Published online: 16 Aug 2006
 

ABSTRACT

The Arabic Scale of Death Anxiety (ASDA) was administered, individually, to 7 groups (N = 765) of Egyptian normal participants (non-clinical), anxiety disorder patients, and patients suffering from schizophrenia (males and females), and addicts (males only). They were generally matched as groups according to age, occupation, and education. The female and male anxiety disorder patients means were, respectively, significantly higher than the means of the other 5 groups on the ASDA, while male schizophrenics attained the lowest mean score in proportion to all the other 6 groups, including the non-clinical 2 groups. All female groups have higher mean scores than their male counterparts.

Many thanks to Professor Robert A. Neimeyer, the Editor-in-Chief of this periodical, as well as two competent anonymous reviewers of the manuscript for their valuable comments and constructive suggestions.

Notes

1Thanks are due to Dr. Eiman Abdel-Hakeem Zayed, PhD, Chief Clinical Psychologist, Hospital of Psychological Medicine, Alexandria, Egypt, for her assistance in administering the scales individually.

Note. F ratio6,763 = 221.4; p < .0001.

*p < .001 (2-tailed)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.